Clinical Trial Update: Phase II, Single-Center, Oral Panobinostat in Combination With Lenalidomide and Dexamethasone in Multiple Myeloma (MM) [Phase 2]

View source ↗

Summary

Phase II, single-center study evaluating a combination of panobinostat, lenalidomide, and dexamethasone in multiple myeloma; results were posted after completio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Farydak (panobinostat)
• Revlimid (lenalidomide)

Snippet

Sponsor: Ajai Chari | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2018-04-09